200,000+ products from a single source!

sales@angenechem.com

Home > Imidazoles > 235-05-2

235-05-2

235-05-2 | Imidazo(1,2-a)quinoxaline

CAS No: 235-05-2 Catalog No: AG002NF2 MDL No:MFCD01720268

Product Description

Catalog Number:
AG002NF2
Chemical Name:
Imidazo(1,2-a)quinoxaline
CAS Number:
235-05-2
Molecular Formula:
C10H7N3
Molecular Weight:
169.1827
MDL Number:
MFCD01720268
IUPAC Name:
imidazo[1,2-a]quinoxaline
InChI:
InChI=1S/C10H7N3/c1-2-4-9-8(3-1)12-7-10-11-5-6-13(9)10/h1-7H
InChI Key:
VTNBGTYLJIUATL-UHFFFAOYSA-N
SMILES:
c1ccc2c(c1)n1ccnc1cn2

Properties

Complexity:
195  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
169.064g/mol
Formal Charge:
0
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
169.187g/mol
Monoisotopic Mass:
169.064g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
30.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.1  

Literature

Title Journal
Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20100131
New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma. European journal of medicinal chemistry 20090901
Quantitation of imidazo[1,2-a]quinoxaline derivatives in human and rat plasma using LC/ESI-MS. Journal of separation science 20090501
In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives. Bioorganic & medicinal chemistry 20080701
Design and synthesis of novel imidazo[1,2-a]quinoxalines as PDE4 inhibitors. Bioorganic & medicinal chemistry 20040301
Imidazo[1,2-a]quinoxalines: synthesis and cyclic nucleotide phosphodiesterase inhibitory activity. European journal of medicinal chemistry 20010301

© 2019 Angene International Limited. All rights Reserved.